乌帕达西替尼 (Upadacitinib) 调节与疼痛相关的途径和BDNF表达在人类单细胞衍生的微质状细胞中
M Vomero1, E Corberi2, O Berardicurti3
1Clinical unit of Immunorheumatology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Roma, Italy; Department of Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21, 00128 Rome, Italy.
Brain, behavior, and immunity
|July 13, 2025
概括
乌帕丁尼 (upa) 是一种JAK1抑制剂,通过降低微状细胞中的脑衍生神经营养因子 (BDNF) 的调节来减少疼痛. 这种治疗促进了抗nociceptive的形状,缓解慢性疼痛在炎症条件下.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性疼痛在炎症性关节炎中持续存在,尽管关节炎症减少.
- 微质细胞通过IL-1β和BDNF等细胞因子促进神经炎症和疼痛.
- 一种JAK1抑制剂Upadacitinib (upa) 在减少疾病活性和疼痛方面表现出有效性,但其缓解疼痛的机制需要澄清.
研究的目的:
- 研究如何UPA影响疼痛和神经炎症相关的分子在人类微状细胞模型.
- 具体来说,要确定upa对BDNF生产及其潜在机制的影响.
主要方法:
- 使用一种亲炎性人类单细胞衍生微状细胞 (M1-MDMi) 细胞模型.
- 在体外应用上达西替尼 (upa) 治疗以抑制JAK1.1.
- 进行了转录组分析,以评估基因表达变化.
主要成果:
- 在Upadacitinib治疗下调了BDNF的表达和分泌.
- 这种下调是通过P2X4受体的调节来调节的.
- 转录组分析显示,UPA通过减少神经炎症和与疼痛相关的途径来诱导一种抗 nociceptive 配置.
结论:
- 由upadacitinib抑制JAK1有效地降低了微状细胞中BDNF的产生.
- 乌帕达西替尼调节P2X4受体,影响中心疼痛感知机制.
- 乌帕达西尼布通过促进抗nociceptive状态,显示出作为慢性疼痛治疗剂的潜力.
相关概念视频
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K


